Catalyst Wire Dossier Catalyst Wire Dossier

bimatoprost 0.03% solution

bimatoprost
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for bimatoprost 0.03% solution, covering 2015-01-14 to 2018-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo [Phase 4]

See pricing